TLS Risk Classification

TLS Prophylaxis: Identification of risk is critical BEFORE starting chemotherapy. High-risk patients (Burkitt, high WBC AML/ALL) require Rasburicase to prevent renal failure.

1. Malignancy Profile

2. Burden Variables

TLS Risk Result

Low Risk

Management Priority

Hydration sufficient

Aggressive Hydration (3L/m²/d)

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Assessing patients before the initiation of chemotherapy for hematologic malignancies.

Identifying high-risk candidates who require aggressive prophylaxis with Rasburicase.

Evaluating patients with bulky solid tumors sensitive to therapy.

Diagnostic Definition (Cairo-Bishop)

Laboratory TLS is defined by ≥ 2 of the following electrolyte abnormalities within 3 days before or 7 days after therapy: Uric Acid > 476 µmol/L (8 mg/dL), Potassium > 6.0 mmol/L, Phosphorus > 1.45 mmol/L, or Calcium < 1.75 mmol/L.

How it Works

High Risk Malignancies

Burkitt Lymphoma (Advanced Stage).

Lymphoblastic Lymphoma (Advanced Stage).

ALL with WBC ≥ 100 × 10⁹/L.

AML with WBC ≥ 100 × 10⁹/L.

Large B-cell Lymphoma with bulky disease (≥ 10 cm) and elevated LDH (> 2x ULN).

Management Paradigm

Risk Class	Primary Prophylaxis
Low Risk	Vigorous Hydration ± Allopurinol
Intermediate	Vigorous Hydration + Allopurinol
High Risk	Vigorous Hydration + Rasburicase (0.2 mg/kg)

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

TLS Risk Classification

Low Risk

When to Use

When to Use

Diagnostic Definition (Cairo-Bishop)

How it Works

High Risk Malignancies

Management Paradigm

Clinical Pearls

The Rasburicase Pivot

Hydration Strategy

The Evidence

Primary Strategy

Tumour lysis syndrome: new therapeutic strategies and classification.

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

Origins & History

History

In Recent Clinical News

TLS Risk Classification

Low Risk

When to Use

When to Use

Diagnostic Definition (Cairo-Bishop)

How it Works

High Risk Malignancies

Management Paradigm

Clinical Pearls

The Rasburicase Pivot

Hydration Strategy

The Evidence

Primary Strategy

Tumour lysis syndrome: new therapeutic strategies and classification.

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

Origins & History

History

In Recent Clinical News